Éva Kocsmár

The correlation between FDG-PET metabolic parameters, PD-L1 expression and p16/HPV status in oropharyngeal cancers

Angéla Horváth, Imre Uri, Emese Kristóf, Gábor Lotz +7 more

2026European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery0 citations

Semantic Scholar

Éva Kocsmár

Most-cited papers

Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides

Sensitivity of Helicobacter pylori detection by Giemsa staining is poor in comparison with immunohistochemistry and fluorescent in situ hybridization and strongly depends on inflammatory activity

Helicobacter pylori heteroresistance to clarithromycin in adults—New data by in situ detection and improved concept

Proteome alterations in human autopsy tissues in relation to time after death

Prognostic Ability of Tumor Budding Outperforms Poorly Differentiated Clusters in Gastric Cancer

Attenuated isolated 3' signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC.

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer

Local Invasion Patterns Characterized by SARIFA and Tumor Budding Differ and Have Distinct Prognostic Significance in Esophageal Adenocarcinoma and Squamous Cell Carcinoma

Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study

Prognostic impact of tumor budding and EMT in periampullary adenocarcinoma: a quantitative approach

Cross-testing of major molecular markers indicates distinct pathways of tumorigenesis in gastric adenocarcinomas and synchronous gastrointestinal stromal tumors

A rapid and concise setup for the fast screening of FRET pairs using bioorthogonalized fluorescent dyes.

Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer.

Autopsy findings in cancer patients infected with SARS-CoV-2 show a milder presentation of COVID-19 compared to non-cancer patients

Dreidimensionale Rekonstruktion solider Tumoren

Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer

Comment on Skrebinska et al. Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection? Diagnostics 2022, 12, 133

The correlation between FDG-PET metabolic parameters, PD-L1 expression and p16/HPV status in oropharyngeal cancers

Stroma AReactive Invasion Front Areas (SARIFA) is a negative prognostic factor for overall survival in non-intestinal gastric adenocarcinomas.

Az ismeretlen kiindulású malignus daganatok (Cancer of Unknown Primary origin; CUP) klinikopatológiája és boncolásalapú osztályozása

Tumor budding morphomic analysis in periampullary and pancreatic cancer reveals prognostic information

[Predictive diagnostics of the programmed cell death receptor 1 (PD-1) - programmed cell death ligand 1 (PD-L1) inhibitory therapies].

[Clinicopathological characterization and autopsybased classification of the Cancer of Unknown Primary origin (CUP) syndrome].

1 / Degree of chromosomal abnormalities detected by UroVysion test predicts progression of non-muscle invasive bladder cancer